INS and Hypoglycemia: These findings align with broader evidence that RT-CGM’s real-time alerts reduce hypoglycemia in insulin-treated patients, as demonstrated in trials by Martens et al. [15], but may have limited impact in populations where hypoglycemia is less prevalent, such as those on non-insulin therapies.